The novel therapy of the medication represents a major breakthrough in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide363538.blogoxo.com/42409065/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment